during a mean follow-up period of 19 +/- 10 months , significant clinical recurrences occurred in 4 of the 10 patients in whom tachycardia could still be initiated with encainide ( with or without isoproterenol ) .
C0039231
tachycardia
C0022245
isoproterenol